Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Contact and information after self-harm pilot study
ISRCTN ISRCTN65171515
ClinicalTrials.gov identifier
Public title Contact and information after self-harm pilot study
Scientific title A pilot study of a contact and information based intervention to reduce repeat self-harm
Acronym N/A
Serial number at source 8434
Study hypothesis The study is funded by the National Institute of Health Research and will be carried out on patients who have recently attended the emergency departments at two hospitals in Manchester following an episode of self-harm.

We plan to recruit between 50 - 100 people over a three month period who have been discharged from the emergency department following self-harm, into the intervention group or the control group. The intervention group will receive an information leaflet providing details of local and national support agencies, followed by two phone calls, and then letters intermittently up to 12 months after recruitment. Both groups will receive their treatment as usual. The rationale for the intervention is to provide contact and facilitate patient access to appropriate treatment. The phone calls and letters will be from a mental health clinician. The main aim of this study is to inform the implementation of a large multicentre randomised control study. We will also investigate whether the intervention reduces repetition of self-harm.
Lay summary
Ethics approval North West 9 Research Ethics Committee - Greater Manchester West approved on the 24th May 2010 (ref: 10/H1014/35)
Study design Single centre randomised interventional treatment trial
Countries of recruitment United Kingdom
Disease/condition/study domain Topic: Mental Health Research Network; Subtopic: Suicide and self-harm; Disease: Suicide and self harm
Participants - inclusion criteria 1. Adults aged over 18 years, either sex
2. Present to the study hospitals with self-harm

Recruitment may take up to three months or we may achieve our target sample size at an earlier stage. "Self-harm" is defined as "an act of intentional self-injury or poisoning irrespective of the apparent purpose of the act". This includes attempts regardless of suicidal intent or medical seriousness and as a definition is in line with that used by NICE guidelines on the short term management of self-harm.
Participants - exclusion criteria 1. Psychiatric in-patients
2. No fixed abode
3. Do not have telephone access
4. Unable to give informed consent during the first telephone call
5. Have been approached at an earlier stage in the study and had refused consent
6. Not able to understand the English language
Anticipated start date 01/04/2010
Anticipated end date 30/09/2011
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Planned sample size: 100; UK sample size: 100
Interventions Patients in the intervention group will receive two phone calls from a clinical researcher soon after hospital attendance, an information leaflet listing local sources of help, and then letters intermittently up to 12 months after recruitment, as well as treatment as usual.

Patients in the control group will receive treatment as usual.

Follow-up length: 12 months
Study entry: single randomisation only
Primary outcome measure(s) To assess the feasibility of a randomised controlled trial (RCT), in particular, recruitment at 6 and/or 12 months
Secondary outcome measure(s) 1. At 12 months we will assess the acceptability of the intervention and help refine it
2. Proportion of patients with at least one repetition of self-harm within 6 and/or 12 months
3. Assess resource use in order to pilot collection of such data
Sources of funding National Institute for Health Research (NIHR) (UK) - Programme Grant for Applied Research (PGfAR)
Trial website
Publications
Contact name Dr  Jayne  Cooper
  Address Oxford Road
  City/town Manchester
  Zip/Postcode M13 9PL
  Country United Kingdom
  Email jayne.cooper@manchester.ac.uk
Sponsor University of Manchester (UK)
  Address Centre for Suicide Prevention
Room 2.320
University Place
Oxford Road
  City/town Manchester
  Zip/Postcode M13 9PL
  Country United Kingdom
  Sponsor website: http://www.manchester.ac.uk/
Date applied 24/06/2010
Last edited 01/07/2010
Date ISRCTN assigned 24/06/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central